Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

583
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
583
Hazard Ratio01:12

Hazard Ratio

701
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
701
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

487
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
487
Censoring Survival Data01:09

Censoring Survival Data

647
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
647
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.6K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy assessment in trials of complex and rare diseases: a comparison between the meta-analytic global statistical test and co-primary analysis.

Frontiers in medical technology·2026
Same author

Gildeuretinol Acetate versus Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The Study of ALK-001 in Geographic Atrophy Randomized Clinical Trial.

Ophthalmology. Retina·2026
Same author

Effects of different early intervention strategies guided by GMOS, PDMS-2, or their combination on motor outcomes in preterm infants with PIVH: a randomized trial.

European journal of medical research·2026
Same author

Leveraging recent advances in plasma biomarkers to optimize early proof of concept trials in Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)·2025
Same author

Expression Profiles of Ferroptosis-Related Genes and Their Diagnostic Value in Infants with Bronchopulmonary Dysplasia.

Pediatric allergy, immunology, and pulmonology·2025
Same author

Analysis and validation of necroptosis-related diagnostic biomarkers associated with immune infiltration in bronchopulmonary dysplasia.

Frontiers in pediatrics·2025

Related Experiment Video

Updated: Mar 29, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Nonparametric covariate adjustment in estimating hazard ratios.

Honghua Jiang1, Pandurang M Kulkarni1, Yanping Wang1

  • 1Eli Lilly and Company, Indianapolis, IN, USA.

Pharmaceutical Statistics
|November 27, 2015
PubMed
Summary

This study evaluates a new method for estimating hazard ratios in clinical trials. The nonparametric analysis of covariance method provides unconditional hazard ratios, overcoming limitations of traditional Cox models.

Keywords:
powertime-to-eventtype I error

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Mar 29, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Survival Analysis

Background:

  • Hazard ratios (HR) quantify treatment effects in time-to-event data.
  • Cox regression models adjust for covariates but yield conditional HRs, unsuitable for unconditional inference.
  • Covariate-adjusted Cox models also impose proportional hazards assumptions.

Purpose of the Study:

  • To evaluate the performance of a nonparametric randomization-based analysis of covariance method for estimating unconditional hazard ratios.
  • To assess the method's power and type I error rate in univariate time-to-event outcomes via simulation.
  • To investigate the impact of stratification on performance.

Main Methods:

  • A nonparametric randomization-based analysis of covariance method was adapted for univariate outcomes.
  • A simulation study was conducted to evaluate performance metrics (power, type I error).
  • Stratified analysis was explored within the simulation framework.

Main Results:

  • The simulation study provides empirical evidence on the performance of the nonparametric method.
  • Results inform the choice between adjusted and unadjusted analyses in time-to-event studies.
  • The method was illustrated using an oncology trial dataset.

Conclusions:

  • The nonparametric analysis of covariance method offers a viable alternative for estimating unconditional hazard ratios.
  • This approach addresses limitations of covariate-adjusted Cox models in clinical trial settings.
  • The study provides crucial performance evaluations for this advanced statistical technique.